Tilray medical applauds german bundestag and landmark passage of medical cannabis act in germany

Cologne, germany and neumÜnster, germany, feb. 23, 2024 (globe newswire) -- tilray brands, inc. (“tilray”) (nasdaq: tlry; tsx: tlry), a global leader in cannabis research, cultivation, production, and distribution, today announced that its medical cannabis division, tilray medical, the global leader in medical cannabis, enthusiastically welcomes the opening of the german medical cannabis market and the positive paradigm shift in german drug policy. today's landmark passage of the german medical cannabis act represents a significant step forward and puts public health in the spotlight while providing patients with easier access to high-quality cannabis medicines produced in germany.
TLRY Ratings Summary
TLRY Quant Ranking